Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 8.
doi: 10.1515/cclm-2025-0481. Online ahead of print.

Proadrenomedullin for prediction of early and mid-term mortality in patients hospitalized for community-acquired pneumonia

Amaia Artaraz  1 , Ane Uranga  1 , Ana Jódar  1 , Urko Aguirre  2 , José María Quintana  2 , Carmen Mar  3 , Rosario Menéndez  4 , Javier Aspa  5 , Salvador Bello  6 , Pedro Pablo España  1 , Aitor Ballaz  1
Affiliations

Proadrenomedullin for prediction of early and mid-term mortality in patients hospitalized for community-acquired pneumonia

Amaia Artaraz et al. Clin Chem Lab Med. .

Abstract

Objectives: Our study sought to determine the usefulness of biomarkers of systemic inflammation (C-reactive protein (CRP), procalcitonin (PCT) and proadrenomedullin (proADM)) on hospital admission, as compared to the CURB65 score, for predicting 30- and 90-day mortality in patients hospitalized for community acquired pneumonia (CAP).

Methods: Observational, prospective study of adults admitted for CAP in four Spanish teaching hospitals. Disease severity was determined within the first 24 h of diagnosis, using the CURB65 score. CRP, PCT and proADM levels were assessed from samples obtained in the Emergency Department (ED). We compared the capacity of the different biomarkers and the CURB65 score to predict pneumonia-related 30- and 90-day mortality.

Results: A total of 956 patients hospitalized with CAP were included, 462 in the internal and 494 in the external sample. Of the biomarkers, proADM showed the greatest AUC for predicting 30- and 90-day mortality (0.80 and 0.76 respectively). Mortality at 30 and 90 days increased as proADM levels rose. When proADM was used as a continuous variable, CURB65 showed a similar predictive capacity (AUC 0.80) to both crude and age-adjusted proADM (AUC 0.80 and 0.83 respectively) for 30-day mortality. The same was also true for 90-day mortality. However, proADM used as a categorical variable had a greater predictive capacity for 90-day mortality than the CURB65 score (<0.001).

Conclusions: Amongst patients admitted for CAP, the use of proADM obtained in the ED may be useful for identifying patients at greatest risk of mortality, with a similar predictive capacity to the CURB65 score.

Keywords: biomarkers of systemic inflammation; community acquired pneumonia; mortality; proadrenodemullin; prognosis.

PubMed Disclaimer

References

    1. Kochanek, KD, Xu, J, Murphy, SL, Miniño, AM, Kung, HC. National vital statistics reports 2012;60:1–115. Available from: https://www.cdc.gov/nchs/data/nvsr/nvsr60/nvsr60_03.pdf .
    1. Almirall, J, Bolibar, I, Vidal, J, Sauca, G, Coll, P, Niklasson, B, et al.. Epidemiology of community-acquired pneumonia in adults: a population-based study. Eur Respir J 2000;15:757–63. https://doi.org/10.1034/j.1399-3003.2000.15d21.x . - DOI
    1. Feagan, BG, Marrie, TJ, Lau, CY, Wheeler, SL, Wong, CJ, Vandervoort, MK. Treatment and outcomes of community-acquired pneumonia at Canadian hospitals. CMAJ 2000;162:1415–20.
    1. Guest, JF, Morris, A. Community-acquired pneumonia: the annual cost to the national health service in the UK. Eur Respir J 1997;10:1530–4. https://doi.org/10.1183/09031936.97.10071530 . - DOI
    1. Fine, MJ, Stone, RA, Singer, DE, Coley, CM, Marrie, TJ, Lave, JR, et al.. Processes and outcomes of care for patients with community-acquired pneumonia. Arch Intern Med 1999;159:970. https://doi.org/10.1001/archinte.159.9.970 . - DOI

LinkOut - more resources